Scottsdale, AZ - Oral anticoagulants are superior to antiplatelet therapy for primary stroke prevention in patients with nonvalvular atrial fibrillation (AF), according to a new report published in ...

Background: The use of antiplatelet therapy in combination with oral anticoagulants remains controversial. The objective of this study was to estimate and compare the incidence of adverse and coronary ...

Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients without a clear indication for ...

Munich, Germany - 28 Aug 2018: Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients ...

Please provide your email address to receive an email when new articles are posted on . Clinical benefits of direct oral anticoagulants in addition to antiplatelet therapy as a secondary prevention ...

Patients with atrial fibrillation who took oral anticoagulants alone after undergoing transcatheter aortic valve replacement (TAVR) had a lower rate of bleeding complications without an increased risk ...

Patients with newly diagnosed atrial fibrillation who take not only an oral anticoagulant (OAC) but also an antiplatelet face increased risks of stroke and bleeding at 1 year, according to an analysis ...

For patients with atrial fibrillation who undergo TAVR, being discharged on antiplatelet therapy seems key in reducing the risk of stroke at 2 years, according to post hoc analysis of PARTNER II data.

PHOENIX -- Anticoagulation worked at least as well as antiplatelet medication for stroke prevention after cervical artery dissection, an observational study suggested. Subsequent ischemic stroke was ...

Please provide your email address to receive an email when new articles are posted on . The multitarget stool DNA test had a positive predictive value of 31.4% for detecting advanced adenomas.

Ischemic adverse events, such as loss of vision and, less frequently, strokes, are the hallmarks of giant cell arteritis (GCA). Antiplatelet and anticoagulant therapy is thought to reduce the risk of ...

Despite favourable results in pivotal clinical trials involving novel direct oral anticoagulants, vitamin K antagonists remain the most commonly prescribed anticoagulant. Newer oral anticoagulants are ...